LPCN LIPOCINE INC NEW revenue, earnings and financials
For the quarter ended June 30, 2026, LIPOCINE INC NEW reported revenue of $190K (down 69.5% from a year earlier), net income of −$2.62M and diluted EPS of −$0.32; over the last four quarters revenue was $1.57M and net income −$11.9M; for the fiscal year ended December 2025 revenue was $1.98M, down 82.3% on the year before.
LPCN annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $1.98M, gross profit n/a, operating income −$10.4M, net income −$9.63M (margin -487.2%), EPS −$1.69
- Fiscal year ended Dec 2024: revenue $11.2M, gross profit n/a, operating income −$1.16M, net income $10.0K (margin 0.1%), EPS n/a
- Fiscal year ended Dec 2023: revenue −$2.85M, gross profit n/a, operating income −$17.9M, net income −$16.4M (margin 573.5%), EPS −$3.14
- Fiscal year ended Dec 2022: revenue $500K, gross profit n/a, operating income −$12.1M, net income −$10.8M (margin -2151.7%), EPS −$2.15
- Fiscal year ended Dec 2021: revenue $16.1M, gross profit n/a, operating income $3.15M, net income −$634K (margin -3.9%), EPS −$0.01
LPCN quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $190K (down 69.5% year over year), net income −$2.62M, EPS −$0.32
- Quarter ended Mar 31, 2026: revenue $119K (up 27.2% year over year), net income −$3.67M, EPS −$0.54
- Quarter ended Dec 31, 2025 (from the annual report): revenue $1.15M, net income −$2.37M, EPS −$0.34
- Quarter ended Sep 30, 2025: revenue $115K, net income −$3.19M, EPS −$0.59
- Quarter ended Jun 30, 2025: revenue $623K (up 595.4% year over year), net income −$2.21M, EPS −$0.41
- Quarter ended Mar 31, 2025: revenue $93.9K (down 98.8% year over year), net income −$1.86M, EPS −$0.35
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income $1.78M, EPS n/a
- Quarter ended Sep 30, 2024: revenue n/a, net income −$2.22M, EPS −$0.44
- Quarter ended Jun 30, 2024: revenue $89.6K, net income −$3.07M, EPS −$0.56
- Quarter ended Mar 31, 2024: revenue $7.62M (up 13751.9% year over year), net income $3.51M, EPS $0.66
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$2.28M, EPS −$0.43
- Quarter ended Sep 30, 2023: revenue −$3.12M, net income −$6.65M, EPS −$1.27
- Quarter ended Jun 30, 2023: revenue n/a, net income −$3.55M, EPS −$0.68
- Quarter ended Mar 31, 2023: revenue $55.0K, net income −$3.87M, EPS −$0.76
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$2.23M, EPS −$0.98
- Quarter ended Sep 30, 2022: revenue n/a, net income −$2.41M, EPS −$0.52
- Quarter ended Jun 30, 2022: revenue $500K, net income −$2.63M, EPS −$0.61
- Quarter ended Mar 31, 2022: revenue n/a, net income −$3.49M, EPS −$0.04
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income $12.6M, EPS $0.15
- Quarter ended Sep 30, 2021: revenue $55.0K, net income −$3.08M, EPS −$0.04
LPCN cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$9.76M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$1.22M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$11.9M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$12.0M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$4.41M, share buybacks n/a
LPCN balance sheet
- Jun 30, 2026: cash $4.98M, total assets $23.8M, total liabilities $2.07M, shareholders' equity $21.8M
- Mar 31, 2026: cash $5.02M, total assets $25.4M, total liabilities $2.53M, shareholders' equity $22.8M
- Dec 31, 2025: cash $5.21M, total assets $17.0M, total liabilities $2.53M, shareholders' equity $14.5M
- Sep 30, 2025: cash $3.90M, total assets $16.1M, total liabilities $1.93M, shareholders' equity $14.1M
- Jun 30, 2025: cash $6.04M, total assets $18.6M, total liabilities $1.45M, shareholders' equity $17.1M
- Mar 31, 2025: cash $3.35M, total assets $20.5M, total liabilities $1.30M, shareholders' equity $19.2M
- Dec 31, 2024: cash $6.21M, total assets $22.5M, total liabilities $1.51M, shareholders' equity $21.0M
- Sep 30, 2024: cash $3.74M, total assets $20.7M, total liabilities $1.58M, shareholders' equity $19.1M
What is LPCN's revenue?
LIPOCINE INC NEW reported $1.57M of revenue over its last four quarters, through June 30, 2026.
Is LPCN profitable?
No. LIPOCINE INC NEW lost $11.9M over the last four quarters.
What is LPCN's EPS?
Diluted earnings per share over the last four quarters were −$1.79; −$0.32 in the latest quarter.